FDA Inspection 1172544 — Sanford Reproductive Medicine

Sanford Reproductive Medicine — FEI 3005043101

The FDA completed an inspection of Sanford Reproductive Medicine on May 31, 2022 in Fargo, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 31, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Fargo, ND (United States)